Literature DB >> 8776888

Characterization of disulfide crosslink formation of human vimentin at the dimer, tetramer, and intermediate filament levels.

K R Rogers1, H Herrmann, W W Franke.   

Abstract

We have investigated the structural interactions of individual molecules of human vimentin in the soluble state and in filaments. Oxidative crosslinking experiments were conducted with wild-type vimentin aimed at the single cysteine in the helical domain coil 2b, mutated cysteine-free vimentin, and derivatives engineered to carry cysteines in presumed d positions of the heptad amino acid repeats in coils 1a and 2b. We provide conclusive evidence that crosslinking of the cysteine 328 in wild-type vimentin, when in the filamentous or tetrameric forms, occurs outside of the coiled-coil dimer, i.e., between staggered dimer molecules. This occurs despite the close axial register of the dimers and contradicts previous deductions. The extent of crosslinking increases with temperature as well as with the concentration of the crosslinking reagent. We conclude therefore that the cysteines are not in an ideal position for crosslinking but that molecular motion is needed to enhance the reaction. The occurrence of collision complexes, which has been speculated in the literature, does not occur and cannot explain these results. Furthermore, using tailless vimentin with the corresponding mutations, we provide compelling evidence that in type III intermediate filament proteins exchange of individual chains between dimers occurs only if the proteins are incubated in urea at concentrations above 3 M. In 5 M urea, however, the exchange is completed within seconds. The same reaction occurs between human vimentin and mouse desmin at a comparable speed, indicating that both type III intermediate filament proteins have a high affinity for one another at the coiled-coil level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8776888     DOI: 10.1006/jsbi.1996.0069

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  17 in total

1.  Real-time observation of coiled-coil domains and subunit assembly in intermediate filaments.

Authors:  John F Hess; John C Voss; Paul G FitzGerald
Journal:  J Biol Chem       Date:  2002-07-16       Impact factor: 5.157

2.  Structural characterization of human vimentin rod 1 and the sequencing of assembly steps in intermediate filament formation in vitro using site-directed spin labeling and electron paramagnetic resonance.

Authors:  John F Hess; Madhu S Budamagunta; John C Voss; Paul G FitzGerald
Journal:  J Biol Chem       Date:  2004-07-01       Impact factor: 5.157

3.  The oxidized thiol proteome in aging and cataractous mouse and human lens revealed by ICAT labeling.

Authors:  Benlian Wang; Grant Hom; Sheng Zhou; Minfei Guo; Binbin Li; Jing Yang; Vincent M Monnier; Xingjun Fan
Journal:  Aging Cell       Date:  2016-11-13       Impact factor: 9.304

4.  Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly.

Authors:  Saima Usman; Hebah Aldehlawi; Thuan Khanh Ngoc Nguyen; Muy-Teck Teh; Ahmad Waseem
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

5.  The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentin.

Authors:  Paola Bargagna-Mohan; Adel Hamza; Yang-eon Kim; Yik Khuan Abby Ho; Nirit Mor-Vaknin; Nicole Wendschlag; Junjun Liu; Robert M Evans; David M Markovitz; Chang-Guo Zhan; Kyung Bo Kim; Royce Mohan
Journal:  Chem Biol       Date:  2007-06

6.  Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis.

Authors:  Paola Bargagna-Mohan; Riya R Paranthan; Adel Hamza; Neviana Dimova; Beatrice Trucchi; Cidambi Srinivasan; Gregory I Elliott; Chang-Guo Zhan; Daniel L Lau; Haiyan Zhu; Kousuke Kasahara; Masaki Inagaki; Franca Cambi; Royce Mohan
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

7.  Treatment of keratin intermediate filaments with sulfur mustard analogs.

Authors:  John F Hess; Paul G FitzGerald
Journal:  Biochem Biophys Res Commun       Date:  2007-05-29       Impact factor: 3.575

8.  Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Authors:  Susmita Samanta; Kurtis Anderson; Sean Moran; David Hawke; David Gorenstein; Myriam Fornage
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  Deconstructing the late phase of vimentin assembly by total internal reflection fluorescence microscopy (TIRFM).

Authors:  Stefan Winheim; Aaron R Hieb; Marleen Silbermann; Eva-Maria Surmann; Tatjana Wedig; Harald Herrmann; Jörg Langowski; Norbert Mücke
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

10.  Bacillus subtilis GlcK activity requires cysteines within a motif that discriminates microbial glucokinases into two lineages.

Authors:  Lili R Mesak; Felix M Mesak; Michael K Dahl
Journal:  BMC Microbiol       Date:  2004-02-03       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.